HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ingo G H Schmidt-Wolf Selected Research

Griseofulvin (Grifulvin V)

1/2017Griseofulvin Efficiently Induces Apoptosis in In Vitro Treatment of Lymphoma and Multiple Myeloma.
10/2014Effect of Wnt inhibitors in pancreatic cancer.
8/2011In vivo efficacy of griseofulvin against multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ingo G H Schmidt-Wolf Research Topics

Disease

68Neoplasms (Cancer)
03/2022 - 06/2002
29Multiple Myeloma
05/2020 - 03/2004
21Lymphoma (Lymphomas)
11/2021 - 06/2002
13Renal Cell Carcinoma (Grawitz Tumor)
04/2020 - 12/2002
7Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 12/2003
6Hepatocellular Carcinoma (Hepatoma)
12/2021 - 04/2006
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2020 - 01/2011
5Hematologic Neoplasms (Hematological Malignancy)
05/2020 - 12/2003
5Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2016 - 11/2003
4Kidney Neoplasms (Kidney Cancer)
04/2020 - 06/2009
4Carcinoma (Carcinomatosis)
09/2019 - 08/2003
4Infections
02/2009 - 05/2002
3Adenocarcinoma
03/2022 - 12/2003
3Prostatic Neoplasms (Prostate Cancer)
01/2017 - 09/2011
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2008 - 11/2002
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2007 - 12/2006
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 04/2020
2Leukemia
03/2015 - 12/2014
2Burkitt Lymphoma (Burkitt's Lymphoma)
12/2014 - 03/2008
2Disease Progression
12/2013 - 02/2006
2Breast Neoplasms (Breast Cancer)
07/2013 - 05/2012
2Fever (Fevers)
02/2012 - 05/2002
2Leukopenia
01/2011 - 04/2006
2Thrombocytopenia (Thrombopenia)
04/2010 - 10/2004
2Neutropenic Enterocolitis
02/2006 - 07/2005
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Hypothyroidism
12/2020
1Hyperthyroidism
12/2020
1Neutropenia
06/2020

Drug/Important Bio-Agent (IBA)

16CytokinesIBA
01/2022 - 04/2006
10AntigensIBA
07/2021 - 01/2004
10CateninsIBA
11/2018 - 05/2011
8Peptides (Polypeptides)IBA
10/2019 - 01/2004
7Lenalidomide (CC 5013)FDA Link
12/2016 - 01/2011
6Pharmaceutical PreparationsIBA
11/2018 - 12/2003
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2017 - 10/2004
6Bortezomib (Velcade)FDA Link
07/2015 - 01/2012
5Cytarabine (Cytosar-U)FDA LinkGeneric
12/2020 - 10/2006
5Ethacrynic Acid (Etacrynic Acid)FDA Link
11/2018 - 12/2009
5Thalidomide (Thalomid)FDA Link
12/2016 - 06/2009
5Dexamethasone (Maxidex)FDA LinkGeneric
04/2016 - 03/2004
4LigandsIBA
07/2020 - 06/2010
4Propidium (Propidium Iodide)IBA
01/2017 - 02/2015
4Rituximab (Mabthera)FDA Link
12/2014 - 10/2004
4beta CateninIBA
12/2014 - 12/2009
4Telomerase (Telomerase Reverse Transcriptase)IBA
01/2007 - 01/2004
3DNA (Deoxyribonucleic Acid)IBA
08/2021 - 06/2002
3VaccinesIBA
07/2021 - 12/2002
3Methotrexate (Mexate)FDA LinkGeneric
12/2020 - 02/2009
3Monoclonal AntibodiesIBA
07/2020 - 03/2007
3Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
06/2020 - 03/2004
3InterferonsIBA
02/2019 - 05/2007
3Ciclopirox (Loprox)FDA LinkGeneric
11/2018 - 01/2014
3Griseofulvin (Grifulvin V)FDA LinkGeneric
01/2017 - 08/2011
33,3'-dihexyl-2,2'-oxacarbocyanineIBA
01/2017 - 02/2015
3IodidesIBA
01/2017 - 03/2015
3Vincristine (Oncovin)FDA LinkGeneric
06/2012 - 03/2004
3RNA (Ribonucleic Acid)IBA
01/2011 - 12/2003
2CannabinoidsIBA
03/2022 - 05/2020
2NivolumabIBA
01/2022 - 04/2020
2Immune Checkpoint InhibitorsIBA
08/2021 - 04/2020
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2021 - 04/2006
2Fetal Proteins (Fetoprotein)IBA
07/2021 - 04/2006
2EnzymesIBA
03/2021 - 07/2008
2Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2019
2micaIBA
07/2020 - 12/2017
2CD40 Ligand (CD40L)IBA
09/2019 - 10/2009
2pomalidomideIBA
12/2016 - 05/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2015 - 04/2006
2piroctone olamineIBA
10/2014 - 01/2014
2Interleukin-12 (IL 12)IBA
03/2014 - 05/2008
2Immunoconjugates (Immunoconjugate)IBA
07/2013 - 04/2010
2KLA peptideIBA
07/2013 - 05/2012
2Interleukin-2 (IL2)IBA
02/2012 - 06/2009
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2012 - 03/2008
2Interferon-gamma (Interferon, gamma)IBA
07/2008 - 03/2003
2Interferon-alpha (Interferon Alfa)IBA
05/2007 - 08/2004
2Antineoplastic Agents (Antineoplastics)IBA
03/2007 - 12/2003
1CannabidiolIBA
03/2022
1CrizotinibIBA
01/2022
1Drug CombinationsIBA
01/2022
1Granzymes (Granzyme)IBA
01/2022
1Long Noncoding RNAIBA
12/2021
1MethyltransferasesIBA
08/2021
1PPAR gammaIBA
08/2021
1Biomarkers (Surrogate Marker)IBA
12/2020
1NeuropilinsIBA
10/2020
1NK Cell Lectin-Like Receptor Subfamily KIBA
07/2020
1CladribineFDA LinkGeneric
06/2020
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
05/2020

Therapy/Procedure

39Therapeutics
01/2022 - 08/2003
23Drug Therapy (Chemotherapy)
12/2020 - 05/2002
21Immunotherapy
01/2022 - 04/2003
7Stem Cell Transplantation
09/2016 - 11/2003
5Salvage Therapy
06/2020 - 10/2006
5Radiotherapy
01/2012 - 12/2003
2Transplantation
01/2016 - 04/2003
2Combination Drug Therapy (Combination Chemotherapy)
02/2010 - 02/2009
1Drug Tapering
06/2020